Internal Medicine, Cardiovascular Disease · Seattle, WA
NPI
1689640351
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
904 7th Ave
Seattle, WA, 98104
Phone (206) 329-1760
Groups this clinician bills Medicare through
Medicare paid, 2024
$290K
7,947 services
Medicare patients, 2024
1,156
Average age 75
Drug cost, 2024
$1.9M
8,074 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter Baciewicz was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 2,775 times for 27 patients. In total Peter Baciewicz billed 7,947 services in 99 codes, and Medicare paid $290K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,775 | 27 | $0.10 | $276 |
| 99214 Office E&M - Established | Office | 612 | 473 | $98.02 | $60K |
| 36415 Venipuncture Blood Collection | Office | 582 | 339 | $8.60 | $5,004 |
| 93000 Electrocardiogram | Office | 508 | 452 | $11.16 | $5,669 |
| 80053 Clinical Chemistry | Office | 350 | 264 | $10.27 | $3,596 |
| 99215 Office E&M - Established | Office | 251 | 175 | $147.06 | $37K |
| 80061 Clinical Chemistry | Office | 237 | 180 | $12.96 | $3,072 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 233 | 58 | $5.55 | $1,293 |
| 93306 Echocardiography (TTE/TEE) | Office | 230 | 223 | $164.35 | $38K |
| 83721 Clinical Chemistry | Office | 221 | 194 | $10.29 | $2,274 |
| 80048 Clinical Chemistry | Office | 194 | 102 | $8.29 | $1,608 |
| 75571 CT/CTA - Chest | Office | 188 | 188 | $84.78 | $16K |
| 85025 Blood Count | Office | 143 | 122 | $7.61 | $1,088 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 137 | 77 | $75.41 | $10K |
| 78452 Myocardial Perfusion Scan | Office | 91 | 90 | $401.90 | $37K |
By year: 2022 $328K for 7,949 services; 2023 $272K for 9,088 services; 2024 $290K for 7,947 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 582 | 339 | $8.60 | $5,004 |
| 80053 Clinical Chemistry | 350 | 264 | $10.27 | $3,596 |
| 80061 Clinical Chemistry | 237 | 180 | $12.96 | $3,072 |
| 83721 Clinical Chemistry | 221 | 194 | $10.29 | $2,274 |
| 80048 Clinical Chemistry | 194 | 102 | $8.29 | $1,608 |
| 85025 Blood Count | 143 | 122 | $7.61 | $1,088 |
| 83880 Clinical Chemistry | 65 | 53 | $38.47 | $2,501 |
| 84443 Clinical Chemistry | 59 | 56 | $16.46 | $971 |
| 82550 Clinical Chemistry | 14 | 13 | $6.38 | $89.32 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter Baciewicz prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,722 prescriptions and refills. In total Peter Baciewicz wrote 8,074 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,722 | 4,873 | 548 | $30K |
| Ezetimibe Generic | 1,084 | 3,070 | 353 | $30K |
| Metoprolol Succinate Generic | 788 | 2,301 | 276 | $12K |
| Eliquis Apixaban | 681 | 1,629 | 197 | $950K |
| Carvedilol Generic | 388 | 1,104 | 120 | $2,731 |
| Atorvastatin Calcium Generic | 329 | 929 | 112 | $3,580 |
| Amlodipine Besylate Generic | 312 | 848 | 102 | $2,352 |
| Spironolactone Generic | 207 | 567 | 64 | $1,271 |
| Lisinopril Generic | 201 | 585 | 69 | $1,510 |
| Jardiance Empagliflozin | 178 | 449 | 55 | $263K |
| Hydrochlorothiazide Generic | 165 | 471 | 59 | $602 |
| Losartan Potassium Generic | 160 | 467 | 65 | $1,494 |
| Olmesartan Medoxomil Generic | 146 | 429 | 51 | $2,314 |
| Furosemide Generic | 130 | 293 | 46 | $513 |
| Repatha Sureclick Evolocumab | 127 | 271 | 37 | $155K |
Brand drugs: 1,406 claims; generic drugs: 6,668 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Peter Baciewicz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.